TGFB1 and cancer: DEG enrichment analysis revealed that pathways in cancer, PI3K‐AKT, Rap1, Hippo, TGF‐β, MAPK, and cAMP signaling were activated, which was consistent with the HPCs from 16 wt (Figure 3C).